Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

Impact of Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Opioid Consumption in Total Hip Arthroplasty Interventions by Posterior Approach

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04574479

Enrollment

Registered

2020-10-05

Start date

2020-12-16

Completion date

2021-09-02

Last updated

2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthropathy of Hip

Brief summary

Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach

Detailed description

ASA physical status 1, 2 and 3 patients scheduled to undergo elective surgery of total hip arthroplasty under spinal anesthesia. The investigators would like to study the impact of supra-inguinal fascia iliaca block on postoperative pain management after total hip arthroplasty by posterior surgical approach. The principal investigator perform this block with ultrasound technique. The investigators also want to observe if this loco-regional new approach to fascia iliaca block could have influence on opioid side effects, postoperative nausea and vomiting, length of hospitalisation and first mobilisation side effects.

Interventions

PROCEDURESupra-inguinal fascia iliaca compartment block

Ultrasound guided loco-regional technique as described by Desmet et al. Fascia iliaca compartment block with in-plane 40 ml ropivacaine 0,375% injection between the ilio-psoas muscle and the internal oblique muscle. Patients in SFICB group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump

DRUGMultimodal analgesia and PCA morphine pump

Patients in placebo group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Investigator)

Masking description

Two group simple-blinded RCT: placebo vs fascia iliaca group. Surgeon and patient are blinded of the patient's group. Investigator and loco-regional technique provider know the patient's group.

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Yes

Inclusion criteria

* Adults patients scheduled to undergo elective surgery of total hip arthroplasty by posterior surgical aboard

Exclusion criteria

* Patient refusal * Allergy to used medications or local infection. * Pregnancy * Obesity with body mass index \> 35 * History of chronic pain or fibromyalgia * Drug (opioids) addiction * Treatment with corticosteroids for more than 6 months * Severe kidney or liver diseases * Mental disorders or serious neurological diseases

Design outcomes

Primary

Measure	Time frame	Description
Opioid sparing	48 hours after the intervention	Difference in cumulated morphine consumption in the first 48 hours after surgery

Secondary

Measure	Time frame	Description
Opioid secondaries effects	48 hours after the intervention	incidence of secondary effects related to morphine consumption
Pain management satisfaction: questionnaire	48 hours after the intervention	pain management satisfaction score by IPO (International Pain Outcomes) questionnaire

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026